StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.45−0.05 (-3.33%)

Close on Nov 18, 2026Market cap $21.92MP/E –Yield –

CervoMed market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

CervoMed's market cap was $23.94M on Nov 11, 2026, against $91.97M a year earlier. Over the last 5 years it ranged from $2.98M to $2.37B, with a median of $36.46M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$23.94M-67.2%
2025Dec 31, 2025$73.10M+278.5%
2024Dec 31, 2024$19.31M-55.4%
2023Dec 29, 2023$43.30M+179.9%
2022Dec 30, 2022$15.47M-99.3%
2021Dec 31, 2021$2.37B-38.3%
2020Dec 31, 2020$3.84B+2268.5%
2019Dec 31, 2019$162.16M-67.8%
2018Dec 31, 2018$503.19M-60.8%
2017Dec 29, 2017$1.28B-26.8%
2016Dec 30, 2016$1.75B+25.6%
2015Dec 31, 2015$1.40B-69.5%
2014Dec 31, 2014$4.58B+383.6%
2013Dec 31, 2013$947.16M-26.4%
2012Dec 31, 2012$1.29B-55.9%
2011Dec 30, 2011$2.92B–

More CervoMed figures

See a number that looks wrong?